Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine Wasting

Purpose: Carnitine is an essential cofactor for mitochondrial fatty acid oxidation that is actively reabsorbed by the luminal transporter Octn2 (Slc22a5). Because the nephrotoxic agent cisplatin causes urinary loss of carnitine in humans, we hypothesized that cisplatin may affect Octn2 function. Exp...

Full description

Bibliographic Details
Main Authors: Lancaster, C., Hu, C., Franke, R., Filipski, K., Orwick, S., Zhaoyuan, C., Zuo, Zhili, Loos, W., Sparreboom, A.
Format: Journal Article
Published: American Association Cancer Research 2010
Online Access:http://hdl.handle.net/20.500.11937/12846
_version_ 1848748190406279168
author Lancaster, C.
Hu, C.
Franke, R.
Filipski, K.
Orwick, S.
Zhaoyuan, C.
Zuo, Zhili
Loos, W.
Sparreboom, A.
author_facet Lancaster, C.
Hu, C.
Franke, R.
Filipski, K.
Orwick, S.
Zhaoyuan, C.
Zuo, Zhili
Loos, W.
Sparreboom, A.
author_sort Lancaster, C.
building Curtin Institutional Repository
collection Online Access
description Purpose: Carnitine is an essential cofactor for mitochondrial fatty acid oxidation that is actively reabsorbed by the luminal transporter Octn2 (Slc22a5). Because the nephrotoxic agent cisplatin causes urinary loss of carnitine in humans, we hypothesized that cisplatin may affect Octn2 function. Experimental Design: Excretion of carnitine and acetylcarnitine was measured in urine collected from mice with or without cisplatin administration. The transport of carnitine was assessed in cells that were transfected with OCT1 or OCT2. The effect of cisplatin treatment on gene expression was analyzed using a mouse GeneChip array and validated using quantitative reverse transcriptase-PCR.Results: In wild-type mice, urinary carnitine excretion at baseline was ∼3-fold higher than in mice lacking the basolateral cisplatin transporters Oct1 and Oct2 [Oct1/2(−/−) mice], indicating that carnitine itself undergoes basolateral uptake into the kidney. Transport of carnitine by OCT2, but not OCT1, was confirmed in transfected cells. We also found that cisplatin caused an increase in the urinary excretion of carnitine and acetylcarnitine in wild-type mice but not in Oct1/2(−/−) mice, suggesting that tubular transport of cisplatin is a prerequisite for this phenomenon. Cisplatin did not directly inhibit the transport of carnitine by Octn2 but downregulated multiple target genes of the transcription factor peroxisome proliferator activated receptor α, including Slc22a5, in the kidney of wild-type mice that were absent in Oct1/2(−/−) mice. Conclusion: Our study shows a pivotal role of Oct1 and Oct2 in cisplatin-related disturbances in carnitine homeostasis. We postulate that this phenomenon is triggered by deactivation of peroxisome proliferator activated receptor α and leads to deregulation of carnitine-shuttle genes.
first_indexed 2025-11-14T07:01:06Z
format Journal Article
id curtin-20.500.11937-12846
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T07:01:06Z
publishDate 2010
publisher American Association Cancer Research
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-128462017-09-13T16:04:16Z Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine Wasting Lancaster, C. Hu, C. Franke, R. Filipski, K. Orwick, S. Zhaoyuan, C. Zuo, Zhili Loos, W. Sparreboom, A. Purpose: Carnitine is an essential cofactor for mitochondrial fatty acid oxidation that is actively reabsorbed by the luminal transporter Octn2 (Slc22a5). Because the nephrotoxic agent cisplatin causes urinary loss of carnitine in humans, we hypothesized that cisplatin may affect Octn2 function. Experimental Design: Excretion of carnitine and acetylcarnitine was measured in urine collected from mice with or without cisplatin administration. The transport of carnitine was assessed in cells that were transfected with OCT1 or OCT2. The effect of cisplatin treatment on gene expression was analyzed using a mouse GeneChip array and validated using quantitative reverse transcriptase-PCR.Results: In wild-type mice, urinary carnitine excretion at baseline was ∼3-fold higher than in mice lacking the basolateral cisplatin transporters Oct1 and Oct2 [Oct1/2(−/−) mice], indicating that carnitine itself undergoes basolateral uptake into the kidney. Transport of carnitine by OCT2, but not OCT1, was confirmed in transfected cells. We also found that cisplatin caused an increase in the urinary excretion of carnitine and acetylcarnitine in wild-type mice but not in Oct1/2(−/−) mice, suggesting that tubular transport of cisplatin is a prerequisite for this phenomenon. Cisplatin did not directly inhibit the transport of carnitine by Octn2 but downregulated multiple target genes of the transcription factor peroxisome proliferator activated receptor α, including Slc22a5, in the kidney of wild-type mice that were absent in Oct1/2(−/−) mice. Conclusion: Our study shows a pivotal role of Oct1 and Oct2 in cisplatin-related disturbances in carnitine homeostasis. We postulate that this phenomenon is triggered by deactivation of peroxisome proliferator activated receptor α and leads to deregulation of carnitine-shuttle genes. 2010 Journal Article http://hdl.handle.net/20.500.11937/12846 10.1158/1078-0432.CCR-10-1239 American Association Cancer Research fulltext
spellingShingle Lancaster, C.
Hu, C.
Franke, R.
Filipski, K.
Orwick, S.
Zhaoyuan, C.
Zuo, Zhili
Loos, W.
Sparreboom, A.
Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine Wasting
title Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine Wasting
title_full Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine Wasting
title_fullStr Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine Wasting
title_full_unstemmed Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine Wasting
title_short Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine Wasting
title_sort cisplatin-induced downregulation of octn2 affects carnitine wasting
url http://hdl.handle.net/20.500.11937/12846